Blocking Molecule Evident in Excess in MS Patients Treats Mice with SPMS-like Disease, Study Reports
Blocking a molecule that is overly abundant in theĀ nervous system of multiple sclerosis (MS) patients, and has been linked to nerve cell damage in animals, worked toĀ significantly ease inflammation, demyelination, and neurodegeneration in mouse modelsĀ of secondary progressive MS (SPMS), a study reports. Treatment…